Cyclic Peptides Tailored to Your Unique Needs
Cyclization Modification
-
Disulfide
-
Lactam
-
Staple
-
Head-to-tail
-
Thioether
-
Additional Modifications
Peptide Cyclization
Cyclic modifications, including disulfide, lactam, staple, head-to-tail, and thioether, offer valuable tools to enhance peptide stability, bioactivity, and pharmacokinetic properties. These modifications have great potential in drug design and development, offering new avenues for therapeutic interventions in various diseases. Continued research and advances in peptide engineering will further expand the applications of cyclic peptides in medicine and other fields.
Disulfide Cyclization
Disulfide cyclization involves the formation of a covalent bond between two cysteine residues within a peptide, leading to the creation of a stable cyclic structure. Disulfide bonds are common in nature and play crucial roles in the stabilization of protein structures. By incorporating disulfide bonds into peptides, their conformational rigidity and proteolytic stability are improved, making them more resistant to enzymatic degradation. Additionally, disulfide-cyclized peptides often show enhanced bioactivity and receptor binding due to the constrained conformation.
Example: Oxytocin is a well-known cyclic peptide hormone containing a disulfide bridge, and its cyclic structure is essential for its biological activity, including its role in inducing labor during childbirth and facilitating social bonding.
Lactam Cyclization
Lactam cyclization involves the formation of an amide bond between two side chains of amino acids within a peptide. This type of cyclization can rigidify the peptide's structure, leading to improved binding affinity and selectivity for the target receptor. Lactam-cyclized peptides often demonstrate enhanced metabolic stability compared to their linear counterparts.
Example: Cilengitide, an experimental anticancer drug, is a cyclic peptide containing a lactam bridge. The lactam cyclization enhances its integrin-binding activity, allowing it to selectively target tumor cells and inhibit angiogenesis.
Staple Cyclization
Staple cyclization employs non-natural linkers, such as hydrocarbon chains or metal complexes, to "staple" together specific segments of a peptide. This strategy induces a defined secondary structure, α-helix, in the peptide, which can improve its cellular penetration and proteolytic stability. Staple-cyclized peptides often exhibit higher resistance to enzymatic degradation and improved pharmacokinetic properties.
Example: The peptide ATSP-7041 is a staple-cyclized α-helical peptide designed to target p53-MDM2/MDMX interactions, which are crucial for cancer development. The staple modification enhances the peptide's binding affinity and cellular uptake, leading to potent anticancer activity.
Head to Tail Cyclization
Head-to-tail cyclization involves connecting the N- and C-termini of a linear peptide to form a cyclic structure. This type of cyclization can stabilize peptide conformations, leading to increased proteolytic stability and bioactivity. Head-to-tail cyclized peptides are commonly used to mimic biologically active motifs or structural elements found in larger proteins.
Example: Cyclosporin A is a cyclic peptide immunosuppressant that derives its potency from head-to-tail cyclization. It functions by inhibiting calcineurin, a protein phosphatase involved in T-cell activation, thereby suppressing the immune response and preventing organ transplant rejection.
Thioether Cyclization
Thioether cyclization involves the formation of a covalent bond between a sulfur atom and another atom, often carbon or nitrogen, within a peptide. Thioether-cyclized peptides are known for their enhanced proteolytic stability and resistance to metabolic degradation, making them promising candidates for therapeutic applications.
QUALITY IS AT THE CORE OF OUR OPERATIONS
We ensure that each peptide we produce adheres to strict internal standards.
This ensures the delivery of the highest quality products. We take pride in our collaborative and customer centric approach that ensures we fully understand the goals for each project we complete.
AT SCITIDE, WE ARE NOT JUST A SERVICE PROVIDER.
We are your dedicated partner in peptide research and development.
Our commitment to excellence extends beyond project completion, as we strive to establish long-lasting relationships with our customers. We take pride in being a reliable resource for all things related to peptide cyclization, offering continuous support to ensure your satisfaction with our services.